Fifth Talcum Powder Cancer Case Set for Trial in April
St. Louis, Missouri—Johnson & Johnson will face a fifth trial beginning April 10th alleging that its popular talcum powder products, baby powder and Shower-to-Shower, have caused ovarian or uterine cancer in women who used them for feminine hygiene. The first three trials resulted in jury verdicts for the women who brought them in the collective amount of $197 million. The fourth trial concluded with a jury verdict in favor of Johnson & Johnson and Imerys Talc America.
All four trials were held in the Missouri 22nd Judicial Circuit Court in St. Louis. The upcoming fifth trial will be heard in that court, as well. It has been brought by Lois Slemp, who alleges that her ovarian cancer was caused by the use of Johnson & Johnson’s talcum powder products.